GlassScriptPhysician profile
Donna J Doherty
NPI 1427669654
$5,750.13
in general payments reported to CMS, 2019-2025
35 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,175 · 2022: $1,279 · 2023: $980 · 2024: $1,844 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,296.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $731.97 | 2021-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $711.37 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $699.20 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $420.65 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $394.62 | 2021-2024 | Jardiance |
| Edwards Lifesciences Corporation | $305.33 | 2021-2025 | Sapien 3 Ultra Resilia |
| Sanofi-Aventis U.S. LLC | $280.04 | 2021-2024 | |
| Abbvie INC. | $250.66 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $159.96 | 2021-2024 | Evkeeza |
| Esperion Therapeutics, INC. | $140.32 | 2021-2025 | Nexletol |
| Inspire Medical Systems, INC. | $138.83 | 2024-2025 | Inspire |
| Harmony Biosciences LLC | $125.00 | 2023 | Wakix |
| Novartis Pharmaceuticals Corporation | $119.24 | 2021-2022 | |
| Scpharmaceuticals INC. | $118.79 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $107.19 | 2022-2024 | Xarelto |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Doherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.